William Hancock, leader in electrocardiography, dies at 93
During his long career at Stanford and into retirement, Hancock advanced techniques used to interpret electrocardiograms, recordings of the heart’s electrical signals. Feb 25 2021
William Hancock
William Hancock, MD, professor emeritus of medicine and pioneer in the use and interpretation of electrocardiograms to screen for heart disease, died Dec. 1. He was 93.
“Bill made exceptional contributions to the field of cardiology during his long and prestigious career at Stanford,” said Lloyd Minor, MD, dean of the School of Medicine. “He will be remembered as a dedicated teacher and mentor and for the groundbreaking techniques he developed for reading ECGs. His lasting impact shaped his field and our community, and Stanford Medicine mourns his loss.”
Jared Tinklenberg, noted Alzheimer’s disease researcher, dies at 80
The founder of the Stanford/Veterans Affairs Alzheimer’s Disease Center, Tinklenberg researched new medications for dementia while providing mentorship to many. Feb 2 2021
Jared Tinklenberg
Jared Tinklenberg, MD, professor emeritus of psychiatry and behavioral science, a leader in Alzheimer’s disease research and a mentor to many, died Nov. 18. He was 80.
Tinklenberg was a clinician and scientist at the Veterans Affairs Palo Alto Health Care System for more than 40 years. He established the Stanford/VA Alzheimer’s Disease Center, which has been in operation at the Palo Alto VA for 20 years. He retired in 2019.
Palo Alto, California – Whitney Dafoe’s day begins at 2:30pm. His father, Ron Davis, peeks through the keyhole into the 37-year-old’s room. Is he awake?
ABSOLUTELY NO ENTRY is scrawled in red on a handmade sign pinned to the door below a picture of the Dalai Lama. Davis has rushed home from Stanford University in Palo Alto, California, to take the afternoon shift. When Whitney raises his left hand, fingers clenched to a fist, that’s Davis’s cue. Whitney is ready for his dad to change his urinal, put ice on his aching belly, and refill the IV-drip.
Purifying widely used antibiotic could reduce risk it poses to hearing, study finds
Scientists have discovered a simple method of reformulating gentamicin, a commonly used and highly effective antibiotic, that could reduce the risk it poses of causing deafness. Dec 17 2020
Alan Cheng and Anthony Ricci are senior authors of a study describing how a component of an antibiotic mixture showed effective antimicrobrial properties but may pose a smaller risk of hearing loss than the mixture. (Photo taken before the COVID-19 pandemic.)
Norbert von der Groeben
A Stanford Medicine-led study has found that a subtype of popular antibiotic could pose a smaller risk of hearing loss yet still be powerful at fighting off bacterial infections.